What to watch with STI Test and Fruchtbarkeit?

When combining an STI test with a fertility test (e.g., MyBody-X), watch for several pitfalls. First, a negative STI test does not rule out past or silent infections – chlamydia and gonorrhea can cause tubal scarring or pelvic inflammatory disease without symptoms, leading to later infertility. Second, DNA-based fertility tests (e.g., on FSH receptor or AMH-related genes) have limited predictive power; they cannot replace clinical workup (hormone panels, semen analysis, imaging). Third, many direct-to-consumer tests blur marketing and evidence – look for CE-IVD marks and physician oversight. Fourth, partner testing is often essential because fertility is a couple issue. Fifth, timing matters: STI tests may have window periods (e.g., HIV, syphilis). In summary: STI screening is evidence-based for fertility health, but consumer genetic fertility tests are mostly exploratory. Always consult a reproductive specialist for actionable decisions.